NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

市場增長機會和預測(2020-2027):按產品,應用,最終用戶劃分的細胞培養市場:全球機會分析和行業預測,2020-2027

Cell Culture Market by Product, Application, End User : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版商 Allied Market Research 商品編碼 991170
出版日期 內容資訊 英文 229 Pages
商品交期: 2-3個工作天內
價格
市場增長機會和預測(2020-2027):按產品,應用,最終用戶劃分的細胞培養市場:全球機會分析和行業預測,2020-2027 Cell Culture Market by Product, Application, End User : Global Opportunity Analysis and Industry Forecast, 2020-2027
出版日期: 2020年12月11日內容資訊: 英文 229 Pages
簡介

在預測期內,全球細胞培養市場預計將以10.9%的複合年增長率增長,從2019年的16,177,700,000美元增長到2027年的36,926,800,000美元。諸如癌症患病率激增,細胞培養技術的採用增加,與研究相關的資金增加以及與癌症相關的研究激增等因素正在推動市場的增長。另一方面,對細胞培養業務進行大量投資的需求正在阻礙市場的進一步增長。

該報告調查了全球細胞培養市場,定義並概述了市場,分析了新的冠狀病毒感染(COVID-19)和其他市場影響因素,市場規模的變化和預測以及產品。例如使用情況,最終用戶,地區/主要國家/地區,競爭環境,主要公司的概況等。

第1章簡介

第2章執行摘要

第3章市場概述

  • 市場定義/範圍
  • 波特的五種力量分析
  • 市場份額分析
  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
    • 影響分析
  • COVID-19的影響

第4章市場分析/預測:按產品分類

  • 設備
    • 生物反應器
    • 細胞培養容器
    • 細胞培養存儲設備
    • 細胞培養支持裝置
  • 消耗品
    • 血清
    • 試劑
    • 生物反應器配件
      • 主要趨勢/增長因素/市場機會
      • 市場規模/預測:按地區
      • 市場分析:按國家

    第5章市場分析/預測:按應用

    • 幹細胞技術
    • 癌症研究
    • 藥物篩選/開發
    • 組織工程/再生醫學
    • 其他
      • 市場規模/預測:按地區
      • 市場分析:按國家

    第6章市場分析/預測:按最終用戶

    • 研究所
    • 製藥和生物技術公司
    • 其他
      • 市場規模/預測:按地區
      • 市場分析:按國家

    第7章市場分析/預測:按地區/主要國家/地區

    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲/中東/非洲
      • 主要趨勢/增長因素/市場機會
      • 市場規模/預測:按產品
      • 市場規模/預測:按應用
      • 市場規模/預測:最終用戶
      • 市場規模/預測:按國家

    第8章公司簡介

    • BECTON, DICKINSON AND COMPANY
    • CORNING INCORPORATED
    • DANHER CORPORATION
    • EPPENDORF AG
    • HIMEDIA LABORATORIES
    • LONZA GROUP LTD
    • MERCK KGAA
    • PROMOCELL GmbH
    • SARTORIUS AG
    • THERMO FISHER SCIENTIFIC, INC.
  • 目錄
    Product Code: A03229

    Title:
    Cell Culture Market by Product (Instrument and Consumables), Application (Stem Cell Technology, Cancer Research, Drug Screening & Development, Tissue Engineering & Regenerative Medicine and Others), End User (Research Institutes, Pharmaceutical &x Biotechnology Companies, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2027.

    The global cell culture market accounted for $16,107.7 million in 2019, and is expected to reach $36,926.8 million by 2027, registering a CAGR of 10.9% from 2020 to 2027.

    A cell culture is defined as the distribution of cells in an artificial environment (in vitro). Furthermore, this artificial environment is composed of all the necessary nutrients such as ideal temperature, gases, pH, and humidity, which are essential for the growth and proliferation of the cells. In addition, the cells are obtained from either plants or animals. There are different types of tools and machines, which are used in producing a cell culture. These machines are called as instruments and there are different types of chemicals, which are also employed in the production of a cell culture.

    These chemicals get used up during the process and hence are called as consumables. For instance, some of the instruments, which are used to produce cell culture include bioreactors, cell culture vessels, and others. Similarly, some of the consumables used in the process include sera, reagents, and others. In addition, cell cultures are of a great importance and hence find their use in fields such as cancer research, stem cell technology, and others.

    For instance, in cancer research, cell cultures enable investigators to tap a renewable source of stable tumor cells for various experiments. In addition, there are different types of industries, which use instruments and consumables to make cell cultures such as research institutes, pharmaceutical & biotechnology companies, and others.

    The major factors that contribute toward the growth of the cell culture market include surge in prevalence of cancer and rise in adoption of cell culture technique. Furthermore, factors such as surge in awareness related to use of cell culture technique in research and increase in research related funding also help boost the market growth. In addition, surge in cancer related research is another major factor that fuels the growth of the market. However, high investment related to cell culture business restricts the growth of the cell culture market. Conversely, expected rise in demand for advanced cell culture technologies offers a lucrative opportunity for the cell culture market growth.

    The global cell culture market is segmented on the basis of product, application, end user, and region to provide a detailed assessment of the market. By product, the market is divided into instruments, and consumables. The instruments segment is further divided into bioreactors, cell culture vessels, cell culture storage equipment, and cell culture supporting instruments. In addition, the consumables segment is divided into sera, media, reagents, and bioreactor accessories. By application, the market is classified into stem cell technology, cancer research, drug screening & development, tissue engineering & regenerative medicine, and others.

    By end user, it is divided into research institutes, pharmaceutical & biotechnology companies and others. By region, the cell culture market size is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

    • Major players operating in the market include, Becton, Dickinson and Company, Corning Incorporated, Eppendorf, Sartorius AG, Merck KGaA, Lonza Group AG, PromoCell GmbH, Danaher Corporation, Thermo Fisher Scientific, and HiMedia Laboratories.
    • KEY BENEFITS FOR STAKEHOLDERS
    • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
    • It offers a quantitative analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
    • A comprehensive analysis of major regions is provided to determine the existing opportunities.
    • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
    • KEY MARKET SEGMENTS

    By Product

    • Consumables
    • Sera
    • Media
    • Reagents
    • Bioreactor Accessories
    • Instruments
    • Bioreactors
    • Cell Culture Vessels
    • Cell Culture Storage Equipment
    • Cell Culture Supporting Instruments

    By Application

    • Stem Cell Technology
    • Cancer Research
    • Drug Screening and Development
    • Tissue Engineering & Regenerative Medicine
    • Others

    By End User

    • Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Others

    By Region

    • North America
    • U.S.
    • Canada
    • Mexico
    • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
    • LIST OF KEY PLAYERS PROFILED IN THE REPORT
    • Becton, Dickinson and Company
    • Corning Incorporated
    • Eppendorf
    • Sartorius AG
    • Merck KGaA
    • Lonza Group AG
    • PromoCell GmbH
    • Danaher Corporation
    • Thermo Fisher Scientific
    • HiMedia Laboratories.
    • LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
    • Agilent
    • Eppendorf AG

    TABLE OF CONTENTS

    CHAPTER 1:INTRODUCTION

    • 1.1.Report description
    • 1.2.Key market segments
      • 1.2.1.List of key players profiled in the report
    • 1.3.Research methodology
      • 1.3.1.Primary research
      • 1.3.2.Secondary research
      • 1.3.3.Analyst tools and models

    CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study
    • 2.2.CXO perspective

    CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope
      • 3.1.1.Top investment pockets
      • 3.1.2.Top winning strategies
    • 3.2.Key forces shaping veterinary medicines industry/Market
    • 3.3.Market share analysis
    • 3.4.Market dynamics
      • 3.4.1.Drivers
        • 3.4.1.1.Prevalence of cancer
        • 3.4.1.2.Increase in adoption of cell culture technique
        • 3.4.1.3.Increase in research funding
      • 3.4.2.Restraints
        • 3.4.2.1.High capital investment
        • 3.4.2.2.Lack of infrastructure for cell-based research
      • 3.4.3.Opportunity
        • 3.4.3.1.Expected rise in demand for advanced technologies
      • 3.4.4.Impact Analyses
    • 3.5.Impact Analysis of COVID-19 on Cell Culture Market

    CHAPTER 4:CELL CULTURE MARKET, BY PRODUCT

    • 4.1.Overview
      • 4.1.1.Market size and forecast
    • 4.2.Instrument
      • 4.2.1.Key findings and opportunity
      • 4.2.2.Market size and forecast, by region
      • 4.2.3.Market analysis by country
        • 4.2.3.1.Bioreactors
        • 4.2.3.2.Cell Culture Vessels
        • 4.2.3.3.Cell Culture Storage Equipment
        • 4.2.3.4.Cell Culture Supporting Instruments
    • 4.3.Consumables
      • 4.3.1.Key findings and opportunity
      • 4.3.2.Market size and forecast, by region
      • 4.3.3.Market analysis by country
        • 4.3.3.1.Sera
        • 4.3.3.2.Media
        • 4.3.3.3.Reagents
        • 4.3.3.4.Bioreactor Accessories

    CHAPTER 5:CELL CULTURE MARKET, BY APPLICATION

    • 5.1.Overview
      • 5.1.1.Market size and forecast
    • 5.2.Stem Cell Technology
      • 5.2.1.Market size and forecast, by region
      • 5.2.2.Market analysis by country
    • 5.3.Cancer Research
      • 5.3.1.Market size and forecast, by region
      • 5.3.2.Market analysis by country
    • 5.4.Drug Screening & Development
      • 5.4.1.Market size and forecast, by region
      • 5.4.2.Market analysis by country
    • 5.5.Tissue Engineering & Regenerative Medicine
      • 5.5.1.Market size and forecast, by region
      • 5.5.2.Market analysis by country
    • 5.6.Others
      • 5.6.1.Market size and forecast, by region
      • 5.6.2.Market analysis by country

    CHAPTER 6:CELL CULTURE MARKET, BY END USER

    • 6.1.Overview
      • 6.1.1.Market size and forecast
    • 6.2.Research Institutes
      • 6.2.1.Market size and forecast, by region
      • 6.2.2.Market analysis by country
    • 6.3.Pharmaceutical & Biotechnology Companies
      • 6.3.1.Market size and forecast, by region
      • 6.3.2.Market analysis by country
    • 6.4.Others
      • 6.4.1.Market size and forecast, by region
      • 6.4.2.Market analysis by country

    CHAPTER 7:CELL CULTURE MARKET, BY REGION

    • 7.1.Overview
      • 7.1.1.Market size and forecast
    • 7.2.North America
      • 7.2.1.Key market trends and opportunities
      • 7.2.2.North America cell culture market, by country
        • 7.2.2.1.U.S. cell culture market, by product type
        • 7.2.2.2.U.S. cell culture market, by application
        • 7.2.2.3.U.S. cell culture market, by end user
        • 7.2.2.4.Canada cell culture market, by product type
        • 7.2.2.5.Canada cell culture market, by application
        • 7.2.2.6.Canada cell culture market, by end user
        • 7.2.2.7.Mexico cell culture market, by product type
        • 7.2.2.8.Mexico cell culture market, by application
        • 7.2.2.9.Mexico cell culture market, by end user
      • 7.2.3.North America cell culture market, by product type
      • 7.2.4.North America cell culture market, by application
      • 7.2.5.North America cell culture market, by end user
    • 7.3.Europe
      • 7.3.1.Key market trends and opportunities
      • 7.3.2.Europe cell culture market, by country
        • 7.3.2.1.Germany cell culture market, by product type
        • 7.3.2.2.Germany cell culture market, by application
        • 7.3.2.3.Germany cell culture market, by end user
        • 7.3.2.4.France cell culture market, by product type
        • 7.3.2.5.France cell culture market, by application
        • 7.3.2.6.France cell culture market, by end user
        • 7.3.2.7.UK cell culture market, by product type
        • 7.3.2.8.UK cell culture market, by application
        • 7.3.2.9.UK cell culture market, by end user
        • 7.3.2.10.Italy cell culture market, by product type
        • 7.3.2.11.Italy cell culture market, by application
        • 7.3.2.12.Italy cell culture market, by end user
        • 7.3.2.13.Spain cell culture market, by product type
        • 7.3.2.14.Spain cell culture market, by application
        • 7.3.2.15.Spain cell culture market, by end user
        • 7.3.2.16.Rest of Europe cell culture market, by product type
        • 7.3.2.17.Rest of Europe cell culture market, by application
        • 7.3.2.18.Rest of Europe cell culture market, by end user
      • 7.3.3.Europe cell culture market, by product type
      • 7.3.4.Europe cell culture market, by application
      • 7.3.5.Europe cell culture market, by end user
    • 7.4.Asia-Pacific
      • 7.4.1.Key market trends and opportunities
      • 7.4.2.Asia-Pacific cell culture market, by country
        • 7.4.2.1.China cell culture market, by product type
        • 7.4.2.2.China cell culture market, by application
        • 7.4.2.3.China cell culture market, by end user
        • 7.4.2.4.Japan cell culture market, by product type
        • 7.4.2.5.Japan cell culture market, by application
        • 7.4.2.6.Japan cell culture market, by end user
        • 7.4.2.7.Australia cell culture market, by product type
        • 7.4.2.8.Australia cell culture market, by application
        • 7.4.2.9.Australia cell culture market, by end user
        • 7.4.2.10.India cell culture market, by product type
        • 7.4.2.11.India cell culture market, by application
        • 7.4.2.12.India cell culture market, by end user
        • 7.4.2.13.South Korea cell culture market, by product type
        • 7.4.2.14.South Korea cell culture market, by application
        • 7.4.2.15.South Korea cell culture market, by end user
        • 7.4.2.16.Rest of Asia-Pacific cell culture market, by product type
        • 7.4.2.17.Rest of Asia-Pacific cell culture market, by application
        • 7.4.2.18.Rest of Asia-Pacific cell culture market, by end user
      • 7.4.3.Asia-Pacific cell culture market, by product type
      • 7.4.4.Asia-Pacific cell culture market, by application
      • 7.4.5.Asia-Pacific cell culture market, by end user
    • 7.5.LAMEA
      • 7.5.1.Key market trends and opportunities
      • 7.5.2.LAMEA cell culture market, by country
        • 7.5.2.1.Brazil cell culture market, by product type
        • 7.5.2.2.Brazil cell culture market, by application
        • 7.5.2.3.Brazil cell culture market, by end user
        • 7.5.2.4.Saudi Arabia cell culture market, by product type
        • 7.5.2.5.Saudi Arabia cell culture market, by application
        • 7.5.2.6.Saudi Arabia cell culture market, by end user
        • 7.5.2.7.South Africa cell culture market, by product type
        • 7.5.2.8.South Africa cell culture market, by application
        • 7.5.2.9.South Africa cell culture market, by end user
        • 7.5.2.10.Rest of LAMEA cell culture market, by product type
        • 7.5.2.11.Rest of LAMEA cell culture market, by application
        • 7.5.2.12.Rest of LAMEA cell culture market, by end user
      • 7.5.3.LAMEA cell culture market, by product type
      • 7.5.4.LAMEA cell culture market, by application
      • 7.5.5.LAMEA cell culture market, by end user

    CHAPTER 8:COMPANY PROFILES

    • 8.1.BECTON, DICKINSON AND COMPANY
      • 8.1.1.Company overview
      • 8.1.2.Company snapshot
      • 8.1.3.Operating business segments
      • 8.1.4.Product portfolio
      • 8.1.5.Business performance
    • 8.2.CORNING INCORPORATED
      • 8.2.1.Company overview
      • 8.2.2.Company snapshot
      • 8.2.3.Operating business segments
      • 8.2.4.Product portfolio
      • 8.2.5.Business performance
      • 8.2.6.Key strategic moves and developments
    • 8.3.DANHER CORPORATION
      • 8.3.1.Company overview
      • 8.3.2.Company snapshot
      • 8.3.3.Operating business segments
      • 8.3.4.Product portfolio
      • 8.3.5.Business performance
    • 8.4.EPPENDORF AG
      • 8.4.1.Company overview
      • 8.4.2.Company snapshot
      • 8.4.3.Operating business segments
      • 8.4.4.Product portfolio
      • 8.4.5.Business performance
    • 8.5.HIMEDIA LABORATORIES
      • 8.5.1.Company overview
      • 8.5.2.Company snapshot
      • 8.5.3.Operating business segments
      • 8.5.4.Product portfolio
    • 8.6.LONZA GROUP LTD
      • 8.6.1.Company overview
      • 8.6.2.Company snapshot
      • 8.6.3.Operating business segments
      • 8.6.4.Operating product portfolio
      • 8.6.5.Business performance
      • 8.6.6.Key strategic moves and developments
    • 8.7.MERCK KGAA
      • 8.7.1.Company overview
      • 8.7.2.Company snapshot
      • 8.7.3.Operating business segments
      • 8.7.4.Product portfolio
      • 8.7.5.Business performance
      • 8.7.6.Key strategic moves and developments
    • 8.8.PROMOCELL GmbH
      • 8.8.1.Company overview
      • 8.8.2.Company snapshot
      • 8.8.3.Operating product segments
      • 8.8.4.Product portfolio
    • 8.9.SARTORIUS AG
      • 8.9.1.Company overview
      • 8.9.2.Company snapshot
      • 8.9.3.Operating business segments
      • 8.9.4.Product portfolio
      • 8.9.5.Business performance
      • 8.9.6.Key strategic moves and developments
    • 8.10.THERMO FISHER SCIENTIFIC, INC.
      • 8.10.1.Company overview
      • 8.10.2.Company snapshot
      • 8.10.3.Operating business segments
      • 8.10.4.Product portfolio
      • 8.10.5.Business performance
      • 8.10.6.Key strategic moves and developments

    LIST OF TABLES

    • TABLE 01.CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
    • TABLE 02.INSTRUMENTS CELL CULTURE MARKET BY REGION 2019-2027, ($MILLION)
    • TABLE 03.CONSUMABLES CELL CULTURE MARKET BY REGION2019-2027, ($MILLION)
    • TABLE 04.CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
    • TABLE 05.CELL CULTURE MARKET FOR STEM CELL TECHNOLOGY, BY REGION 2019-2027($MILLION)
    • TABLE 06.CELL CULTURE MARKET FOR CANCER RESEARCH, BY REGION 2019-2027 ($MILLION)
    • TABLE 07.CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION 2019-2027 ($MILLION)
    • TABLE 08.CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION

    2019-2027 ($MILLION)

    • TABLE 09.CELL CULTURE MARKET FOR OTHERS, BY REGION 2019-2027 ($MILLION)
    • TABLE 10.CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
    • TABLE 11.CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION 2019-2027($MILLION)
    • TABLE 12.CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION 2019-2027 ($MILLION)
    • TABLE 13.CELL CULTURE MARKET FOR OTHERS, BY REGION 2019-2027 ($MILLION)
    • TABLE 14.CELL CULTURE MARKET REVENUE, BY REGION, 2019-2027($MILLION)
    • TABLE 15.NORTH AMERICA CELL CULTURE MARKET, BY COUNTRY, 2019-2027($MILLION)
    • TABLE 16.U.S. CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 17.U.S. CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 18.U.S. CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 19.CANADA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 20.CANADA CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 21.CANADA CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 22.MEXICO CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 23.MEXICO CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 24.MEXICO CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 25.NORTH AMERICA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 26.NORTH AMERICA CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 27.NORTH AMERICA CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 28.EUROPE CELL CULTURE MARKET, BY COUNTRY, 2019-2027($MILLION)
    • TABLE 29.GERMANY CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 30.GERMANY CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 31.GERMANY CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 32.FRANCE CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 33.FRANCE CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 34.FRANCE CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 35.UK CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 36.UK CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 37.UK CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 38.ITALY CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 39.ITALY CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 40.ITALY CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 41.SPAIN CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 42.SPAIN CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 43.SPAIN CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 44.REST OF EUROPE CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 45.REST OF EUROPE CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 46.REST OF EUROPE CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 47.EUROPE CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 48.EUROPE CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 49.EUROPE CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 50.ASIA-PACIFIC CELL CULTURE MARKET, BY COUNTRY, 2019-2027($MILLION)
    • TABLE 51.JAPAN CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 52.CHINA CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 53.CHINA CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 54.JAPAN CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 55.JAPAN CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 56.CHINA CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 57.AUSTRALIA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 58.AUSTRALIA CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 59.AUSTRALIA CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 60.INDIA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 61.INDIA CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 62.INDIA CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 63.SOUTH KOREA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 64.SOUTH KOREA CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 65.SOUTH KOREA CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 66.REST OF ASIA-PACIFIC CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 67.REST OF ASIA-PACIFIC CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 68.REST OF ASIA-PACIFIC CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 69.ASIA-PACIFIC CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 70.ASIA-PACIFIC CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 71.ASIA-PACIFIC CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 72.LAMEA CELL CULTURE MARKET, BY COUNTRY, 2019-2027($MILLION)
    • TABLE 73.BRAZIL CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 74.BRAZIL CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 75.BRAZIL CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 76.SAUDI ARABIA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 77.SAUDI ARABIA CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 78.SAUDI ARABIA CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 79.SOUTH AFRICA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 80.SOUTH AFRICA CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 81.SOUTH AFRICA CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 82.REST OF LAMEA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 83.REST OF LAMEA CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 84.REST OF LAMEA CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 85.LAMEA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
    • TABLE 86.LAMEA CELL CULTURE MARKET, BY APPLICATION, 2019-2027($MILLION)
    • TABLE 87.LAMEA CELL CULTURE MARKET, BY END USER, 2019-2027($MILLION)
    • TABLE 88.BD: SNAPSHOT
    • TABLE 89.BD: OPERATING SEGMENTS
    • TABLE 90.BD: PRODUCT PORTFOLIO
    • TABLE 91.CORNING: COMPANY SNAPSHOT
    • TABLE 92.CORNING: OPERATING SEGMENT
    • TABLE 93.CORNING: PRODUCT PORTFOLIO
    • TABLE 94.CORNING: KEY STRATEGIC MOVES AND DEVELOPMENTS
    • TABLE 95.DANAHER: COMPANY SNAPSHOT
    • TABLE 96.DANAHER: OPERATING SEGMENTS
    • TABLE 97.DANAHER: PRODUCT PORTFOLIO
    • TABLE 98.EPPENDORF: COMPANY SNAPSHOT
    • TABLE 99.EPPENDORF: PRODUCT PORTFOLIO
    • TABLE 100.HIMEDIA: COMPANY SNAPSHOT
    • TABLE 101.HIMEDIA:OPERATING PRODUCT SEGMENT
    • TABLE 102.HIMEDIA: PRODUCT PORTFOLIO
    • TABLE 103.LONZA: COMPANY SNAPSHOT
    • TABLE 104.PRODUCT PORTFOLIO
    • TABLE 105.LONZA: PRODUCT PORTFOLIO
    • TABLE 106.LONZA: KEY STRATEGIC MOVES AND DEVELOPMENTS
    • TABLE 107.MERCK: COMPANY SNAPSHOT
    • TABLE 108.MERCK: OPERATING SEGMENTS
    • TABLE 109.MERCK: PRODUCT PORTFOLIO
    • TABLE 110.MERCK: KEY STRATEGIC MOVES AND DEVELOPMENTS
    • TABLE 111.PROMOCELL: COMPANY SNAPSHOT
    • TABLE 112.PROMOCELL: PRODUCT PORTFOLIO
    • TABLE 113.SARTORIUS: COMPANY SNAPSHOT
    • TABLE 114.SARTORIUS: OPERATING BUSINESS SEGMENTS
    • TABLE 115.SARTORIUS: PRODUCT PORTFOLIO
    • TABLE 116.SARTORIUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
    • TABLE 117.THERMO FISHER: COMPANY SNAPSHOT
    • TABLE 118.THERMO FISHER.: OPERATING SEGMENTS
    • TABLE 119.THERMO FISHER.: PRODUCT PORTFOLIO
    • TABLE 120.THERMO FISHER: KEY STRATEGIC MOVES AND DEVELOPMENTS

    LIST OF FIGURES

    • FIGURE 01.GLOBAL CELL CULTURE MARKET SEGMENTATION
    • FIGURE 02.TOP INVESTMENT POCKETS
    • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2020*
    • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2020* (%)
    • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2020*
    • FIGURE 06.HIGH BARGAINING POWER OF SUPPLIER
    • FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
    • FIGURE 08.HIGH THREAT OF SUBSTITUTES
    • FIGURE 09.MODERATE INTENSITY OF RIVALRY
    • FIGURE 10.LOW THREAT OF NEW ENTRANT
    • FIGURE 11.MARKET SHARE ANALYSIS
    • FIGURE 12.IMPACT ANALYSES, CELL CULTURE MARKET
    • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF INSTRUMENTS CELL CULTURE MARKET BY COUNTRY,

    2019 & 2027 (%)

    • FIGURE 14.BIOREACTORS IN CELL CULTURE MARKET, 2019 & 2027 ($MILLION)
    • FIGURE 15.CELL CULTURE VESSELS IN CELL CULTURE MARKET, 2019 & 2027 ($MILLION)
    • FIGURE 16.CELL CULTURE STORAGE EQUIPMENT IN CELL CULTURE MARKET, 2019 & 2027 ($MILLION)
    • FIGURE 17.CELL CULTURE SUPPORTING INSTRUMENTS IN CELL CULTURE MARKET, 2019 & 2027 ($MILLION)
    • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES CELL CULTURE MARKET, BY COUNTRY,

    2019 & 2027 (%)

    • FIGURE 19.SERA IN CELL CULTURE MARKET, 2019 & 2027 ($MILLION)
    • FIGURE 20.MEDIA IN CELL CULTURE MARKET, 2019 & 2027 ($MILLION)
    • FIGURE 21.REAGENTS IN CELL CULTURE MARKET, 2019 & 2027 ($MILLION)
    • FIGURE 22.BIOREACTOR ACCESSORIES IN CELL CULTURE MARKET, 2019 & 2027 ($MILLION)
    • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE MARKET FOR STEM CELL TECHNOLOGY,

    BY COUNTRY, 2019 & 2027 (%)

    • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE MARKET FOR CANCER RESEARCH, BY COUNTRY, 2019 & 2027 (%)
    • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019 & 2027 (%)
    • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019 & 2027 (%)
    • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE MARKET FOR OTHERS, BY COUNTRY,
    • 2019 & 2027 (%)
    • FIGURE 28.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE MARKET FOR RESEARCH INSTITUTES,

    BY COUNTRY, 2019 & 2027 (%)

    • FIGURE 29.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019 & 2027 (%)
    • FIGURE 30.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE MARKET FOR OTHERS, BY COUNTRY,
    • 2019 & 2027 (%)
    • FIGURE 31.CANCER INCIDENCES IN GERMANY (2007 & 2050)
    • FIGURE 32.BD: NET SALES, 2017-2019 ($MILLION)
    • FIGURE 33.BD: REVENUE SHARE BY SEGMENT, 2019 (%)
    • FIGURE 34.BD: REVENUE SHARE, BY REGION, 2019 (%)
    • FIGURE 35.CORNING: NET SALES, 2017-2019 ($MILLION)
    • FIGURE 36.CORNING: REVENUE SHARE, BY SEGMENT, 2019 (%)
    • FIGURE 37.CORNING: REVENUE SHARE, BY REGION, 2019 (%)
    • FIGURE 38.DANAHER: NET SALES, 2017-2019 ($MILLION)
    • FIGURE 39.DANAHER: REVENUE SHARE BY SEGMENT, 2019 (%)
    • FIGURE 40.DANAHER: REVENUE SHARE BY REGION, 2019 (%)
    • FIGURE 41.EPPENDORF: NET SALES, 2017-2019 ($MILLION)
    • FIGURE 42.EPPENDORF: REVENUE SHARE, BY REGION, 2019 (%)
    • FIGURE 43.LONZA: NET SALES, 2017-2019 ($MILLION)
    • FIGURE 44.LONZA: REVENUE SHARE, BY SEGMENT, 2019 (%)
    • FIGURE 45.MERCK: NET SALES, 2017-2019 ($MILLION)
    • FIGURE 46.MERCK: REVENUE SHARE, BY SEGMENT, 2019 (%)
    • FIGURE 47.MERCK: REVENUE SHARE, BY REGION, 2019 (%)
    • FIGURE 48.SARTORIUS: NET SALES, 2017-2019 ($MILLION)
    • FIGURE 49.SARTORIUS: REVENUE SHARE BY SEGMENT, 2019 (%)
    • FIGURE 50.SARTORIUS: REVENUE SHARE BY REGION, 2019 (%)
    • FIGURE 51.THERMO FISHER: NET SALES, 2017-2019 ($MILLION)
    • FIGURE 52.THERMO FISHER: REVENUE SHARE, BY SEGMENT, 2019 (%)
    • FIGURE 53.THERMO FISHER: REVENUE SHARE, BY REGION, 2019 (%)